Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company NanoVector Inc.
DescriptionRed clover necrotic mosaic virus (RCNMV)-based nanoparticle drug delivery vector
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationMelanoma
Indication DetailsTreat metastatic melanoma
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today